348 related articles for article (PubMed ID: 30417713)
1. Controversies in the pharmacological treatment of Graves' disease in children.
De Luca F; Valenzise M
Expert Rev Clin Pharmacol; 2018 Nov; 11(11):1113-1121. PubMed ID: 30417713
[TBL] [Abstract][Full Text] [Related]
2. Management of hyperthyroidism in children.
De Luca F; Salzano G; Zirilli G; Calafiore M; Corica D; Sferlazzas C
Expert Rev Endocrinol Metab; 2016 Jul; 11(4):301-309. PubMed ID: 30058924
[TBL] [Abstract][Full Text] [Related]
3. Evaluation and Management of Children with Thyrotoxicosis.
Leung AKC; Leung AAC
Recent Pat Endocr Metab Immune Drug Discov; 2017; 11(1):22-31. PubMed ID: 29589552
[TBL] [Abstract][Full Text] [Related]
4. Management of Graves' hyperthyroidism: present and future.
Bartalena L; Piantanida E; Gallo D; Ippolito S; Tanda ML
Expert Rev Endocrinol Metab; 2022 Mar; 17(2):153-166. PubMed ID: 35287535
[TBL] [Abstract][Full Text] [Related]
5. Thyrotoxicosis.
Franklyn JA; Boelaert K
Lancet; 2012 Mar; 379(9821):1155-66. PubMed ID: 22394559
[TBL] [Abstract][Full Text] [Related]
6. Investigational drugs in early stage clinical trials for thyrotoxicosis with hyperthyroidism.
Gómez-Sáez JM
Expert Opin Investig Drugs; 2018 Nov; 27(11):831-837. PubMed ID: 30354697
[TBL] [Abstract][Full Text] [Related]
7. Pediatric Graves' disease: controversies in management.
Rivkees SA
Horm Res Paediatr; 2010; 74(5):305-11. PubMed ID: 20924158
[TBL] [Abstract][Full Text] [Related]
8. Impaired Quality of Life After Radioiodine Therapy Compared to Antithyroid Drugs or Surgical Treatment for Graves' Hyperthyroidism: A Long-Term Follow-Up with the Thyroid-Related Patient-Reported Outcome Questionnaire and 36-Item Short Form Health Status Survey.
Törring O; Watt T; Sjölin G; Byström K; Abraham-Nordling M; Calissendorff J; Cramon PK; Filipsson Nyström H; Hallengren B; Holmberg M; Khamisi S; Lantz M; Wallin G
Thyroid; 2019 Mar; 29(3):322-331. PubMed ID: 30667296
[TBL] [Abstract][Full Text] [Related]
9. Persistent remission of Graves` disease or evolution from Graves' disease to Hashimoto's thyroiditis in childhood - a report of 6 cases and clinical implications.
Smyczńyska J; Cyniak-Magierska A; Stasiak M; Karbownik-Lewińska M; Lewiński A
Neuro Endocrinol Lett; 2014; 35(5):335-41. PubMed ID: 25275265
[TBL] [Abstract][Full Text] [Related]
10. Comparative Effectiveness of Treatment Choices for Graves' Hyperthyroidism: A Historical Cohort Study.
Sundaresh V; Brito JP; Thapa P; Bahn RS; Stan MN
Thyroid; 2017 Apr; 27(4):497-505. PubMed ID: 28049375
[TBL] [Abstract][Full Text] [Related]
11. Graves' disease in children.
Léger J; Oliver I; Rodrigue D; Lambert AS; Coutant R
Ann Endocrinol (Paris); 2018 Dec; 79(6):647-655. PubMed ID: 30180972
[TBL] [Abstract][Full Text] [Related]
12. Definitive treatment of Graves' disease in children and adolescents.
Król A; Czarniecka A; Jarząb B
Endokrynol Pol; 2021; 72(6):661-665. PubMed ID: 34855196
[TBL] [Abstract][Full Text] [Related]
13. [Radioiodine versus surgery in the treatment of Graves' hyperthyroidism].
Jukić T; Stanicić J; Petric V; Kusić Z
Lijec Vjesn; 2010; 132(11-12):355-60. PubMed ID: 21294325
[TBL] [Abstract][Full Text] [Related]
14. Current approach to surgical management of hyperthyroidism.
Barczyński M
Q J Nucl Med Mol Imaging; 2021 Jun; 65(2):124-131. PubMed ID: 33494587
[TBL] [Abstract][Full Text] [Related]
15. Controversies related to the medical and surgical management of hyperthyroidism in children.
Waldhausen JH
Semin Pediatr Surg; 1997 Aug; 6(3):121-7. PubMed ID: 9263333
[TBL] [Abstract][Full Text] [Related]
16. TSH-receptor autoimmunity in Graves' disease after therapy with anti-thyroid drugs, surgery, or radioiodine: a 5-year prospective randomized study.
Laurberg P; Wallin G; Tallstedt L; Abraham-Nordling M; Lundell G; Tørring O
Eur J Endocrinol; 2008 Jan; 158(1):69-75. PubMed ID: 18166819
[TBL] [Abstract][Full Text] [Related]
17. Treatment of Graves' disease in children: The Portuguese experience.
Marques O; Antunes A; Oliveira MJ
Endocrinol Diabetes Nutr (Engl Ed); 2018 Mar; 65(3):143-149. PubMed ID: 29325833
[TBL] [Abstract][Full Text] [Related]
18. Hyperthyroidism and other causes of thyrotoxicosis: management guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists.
Bahn Chair RS; Burch HB; Cooper DS; Garber JR; Greenlee MC; Klein I; Laurberg P; McDougall IR; Montori VM; Rivkees SA; Ross DS; Sosa JA; Stan MN; ;
Thyroid; 2011 Jun; 21(6):593-646. PubMed ID: 21510801
[TBL] [Abstract][Full Text] [Related]
19. Management of Graves Disease: A Review.
Burch HB; Cooper DS
JAMA; 2015 Dec; 314(23):2544-54. PubMed ID: 26670972
[TBL] [Abstract][Full Text] [Related]
20. Benefit of short-term iodide supplementation to antithyroid drug treatment of thyrotoxicosis due to Graves' disease.
Takata K; Amino N; Kubota S; Sasaki I; Nishihara E; Kudo T; Ito M; Fukata S; Miyauchi A
Clin Endocrinol (Oxf); 2010 Jun; 72(6):845-50. PubMed ID: 19912243
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]